|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
EBOOKCENTRAL_ocn785373830 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
120411s2012 dcua ob 100 0 eng d |
040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d IDEBK
|d NTE
|d CDX
|d YDXCP
|d OCLCQ
|d OCLCF
|d DKDLA
|d OCLCQ
|d OCLCO
|d OCLCQ
|d CIT
|d MMU
|d UCNAP
|d E7B
|d UKMGB
|d OCLCQ
|d OCL
|d OCLCO
|d EBLCP
|d OCLCO
|d OCLCQ
|d OCLCO
|d NKT
|d TOA
|d AGLDB
|d ZCU
|d OCLCQ
|d MERUC
|d OCLCQ
|d OCLCO
|d OCLCA
|d U3W
|d OCLCA
|d BUF
|d OCLCO
|d VT2
|d OCLCO
|d VNS
|d VTS
|d UAB
|d ICG
|d MERER
|d REC
|d OCLCQ
|d WYU
|d OCLCO
|d OCLCA
|d LVT
|d OCLCA
|d S9I
|d STF
|d DKC
|d OCLCO
|d OCLCQ
|d M8D
|d OCLCQ
|d OCLCA
|d UKAHL
|d OCLCA
|d AJS
|d OCLCQ
|d OCLCO
|d SFB
|d OCLCQ
|d OCLCO
|d OCLCL
|
016 |
7 |
|
|a 016092846
|2 Uk
|
019 |
|
|
|a 776753580
|a 785337634
|a 794491570
|a 817067884
|a 824114298
|a 847597145
|a 923289118
|a 1021256324
|a 1028770976
|a 1048167185
|a 1055312373
|a 1065825798
|a 1081246063
|a 1156373622
|a 1204378352
|a 1204379712
|a 1228611923
|a 1249235957
|
020 |
|
|
|a 9780309220651
|q (electronic bk.)
|
020 |
|
|
|a 0309220653
|q (electronic bk.)
|
020 |
|
|
|a 1280123346
|
020 |
|
|
|a 9781280123344
|
020 |
|
|
|z 9780309220644
|
020 |
|
|
|z 0309220645
|
029 |
1 |
|
|a AU@
|b 000051482375
|
029 |
1 |
|
|a DEBBG
|b BV042794605
|
029 |
1 |
|
|a DEBBG
|b BV044109376
|
029 |
1 |
|
|a DEBSZ
|b 421432373
|
029 |
1 |
|
|a GBVCP
|b 803955936
|
029 |
1 |
|
|a NZ1
|b 14973780
|
029 |
1 |
|
|a AU@
|b 000054187296
|
035 |
|
|
|a (OCoLC)785373830
|z (OCoLC)776753580
|z (OCoLC)785337634
|z (OCoLC)794491570
|z (OCoLC)817067884
|z (OCoLC)824114298
|z (OCoLC)847597145
|z (OCoLC)923289118
|z (OCoLC)1021256324
|z (OCoLC)1028770976
|z (OCoLC)1048167185
|z (OCoLC)1055312373
|z (OCoLC)1065825798
|z (OCoLC)1081246063
|z (OCoLC)1156373622
|z (OCoLC)1204378352
|z (OCoLC)1204379712
|z (OCoLC)1228611923
|z (OCoLC)1249235957
|
043 |
|
|
|a n-us---
|
050 |
|
4 |
|a RC268
|
060 |
|
4 |
|a QZ 267
|
072 |
|
7 |
|a HEA
|x 039030
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 062000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.99/405
|2 23
|
049 |
|
|
|a UAMI
|
110 |
2 |
|
|a National Cancer Policy Forum (U.S.)
|
245 |
1 |
0 |
|a Facilitating Collaborations to Develop Combination Investigational Cancer Therapies :
|b Workshop Summary /
|c Margie Patlak, Sharyl J. Nass, and Erin Balogh, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies.
|
260 |
|
|
|a Washington, D.C. :
|b National Academies Press,
|c ©2012.
|
300 |
|
|
|a 1 online resource (xiii, 103 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a data file
|
500 |
|
|
|a Workshop on 'Facilitating Collaborations to Develop Combination Investigational Cancer Therapies' was held June 13-14, 2011, National Academy of Sciences, Washington, D.C.
|
504 |
|
|
|a Includes bibliographical references (pages 97-99).
|
520 |
|
|
|a "Advances in biomedical research have increased our understanding of the complex nature of disease and the interaction of multiple molecular pathways involved in cancer. Combining investigational products early in their development is thought to be a promising strategy for identifying effective therapies. The IOM's National Cancer Policy Forum held a workshop to discuss challenges and identify potential solutions to improve collaboration and advance the development of combination investigational cancer therapies."--Publisher's description
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Introduction -- Why Combinations and Collaborations Are Necessary -- Scientific Challenges in Developing Investigational Combination Therapies -- Overcoming Cultural Challenges to Collaborations Legal Issues in Collaborations -- Financial Challenges -- Regulatory Issues -- Codevelopment of Therapies for HIV as a Model -- Examples of Collaborations Relevant to Cancer -- Wrapping Up -- Appendix A: Examples of Collaborations -- Appendix B: Workshop Agenda -- References -- Acronyms.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Cancer
|x Research
|z United States
|v Congresses.
|
650 |
|
0 |
|a Cancer
|x Treatment
|v Congresses.
|
650 |
|
0 |
|a Cancer
|z United States
|x Prevention
|v Congresses.
|
650 |
|
0 |
|a Health planning
|z United States
|v Congresses.
|
650 |
1 |
2 |
|a Neoplasms
|x drug therapy
|
650 |
1 |
2 |
|a Drug Therapy, Combination
|
650 |
2 |
2 |
|a Antineoplastic Agents
|x therapeutic use
|
650 |
2 |
2 |
|a Cooperative Behavior
|
651 |
|
2 |
|a United States
|
650 |
|
6 |
|a Cancer
|x Recherche
|z États-Unis
|v Congrès.
|
650 |
|
6 |
|a Cancer
|x Traitement
|v Congrès.
|
650 |
|
6 |
|a Cancer
|z États-Unis
|x Prévention
|v Congrès.
|
650 |
|
6 |
|a Santé publique
|x Planification
|z États-Unis
|v Congrès.
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x Cancer.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Oncology.
|2 bisacsh
|
650 |
|
7 |
|a Cancer
|x Prevention
|2 fast
|
650 |
|
7 |
|a Cancer
|x Research
|2 fast
|
650 |
|
7 |
|a Cancer
|x Treatment
|2 fast
|
650 |
|
7 |
|a Health planning
|2 fast
|
651 |
|
7 |
|a United States
|2 fast
|1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq
|
655 |
|
2 |
|a Congress
|
655 |
|
7 |
|a proceedings (reports)
|2 aat
|
655 |
|
7 |
|a Conference papers and proceedings
|2 fast
|
655 |
|
7 |
|a Conference papers and proceedings.
|2 lcgft
|
655 |
|
7 |
|a Actes de congrès.
|2 rvmgf
|
700 |
1 |
|
|a Patlak, Margie.
|
700 |
1 |
|
|a Nass, Sharyl J.
|
700 |
1 |
|
|a Balogh, Erin.
|
710 |
2 |
|
|a National Cancer Policy Forum (U.S.)
|
710 |
2 |
|
|a Institute of Medicine (U.S.).
|b Board on Health Care Services.
|
758 |
|
|
|i has work:
|a Facilitating Collaborations to Develop Combination Investigational Cancer Therapies (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCGPFc7Vc4gw6TpyQM6Bqw3
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
0 |
8 |
|i Print version:
|a Facilitating Collaborations to Develop Combination Investigational Cancer Therapies (2011 : Washington, D.C.).
|t Facilitating Collaborations to Develop Combination Investigational Cancer Therapies.
|d Washington, D.C. : National Academies Press, ©2012
|z 9780309220644
|w (DLC) 2011278592
|w (OCoLC)778637018
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3378946
|z Texto completo
|
938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH36559688
|
938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH36617487
|
938 |
|
|
|a Coutts Information Services
|b COUT
|n 21789456
|
938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL3378946
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr10554791
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 444959
|
938 |
|
|
|a ProQuest MyiLibrary Digital eBook Collection
|b IDEB
|n 352720
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 7608234
|
994 |
|
|
|a 92
|b IZTAP
|